RecruitingNCT07313384

Dietary Insights and Nutrition Experiences in Adults on GLP-1 Therapy - A Study on Diet Quality Changes in Adults on GLP-1 Therapy


Sponsor

University of South Carolina

Enrollment

50 participants

Start Date

Feb 11, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

The DINE-GLP1 study aims to understand how people on GLP-1 therapy change their eating habits and what kind of dietary support they need. As more people use GLP-1 medications, there's not much guidance on what they should eat, mostly just focusing on managing symptoms and cutting calories. Since these medications reduce food intake, it's important to ensure the diet is nutritious even with fewer calories to help with long-term weight control and health. Most research has looked at how the body responds to the medication and whether patients take it as prescribed, but not much is known about what patients actually experience, what they think they need, or how they could use additional support. Understanding patients' views can help create better lasting solutions. Note that this study does not provide free GLP-1 medication.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study collects information about how diet quality and nutrition change in adults who are starting a GLP-1 medication (such as semaglutide/Ozempic or tirzepatide) for obesity or type 2 diabetes. It uses short surveys and online food recalls to track changes over time. **You may be eligible if...** - You are 18 or older - You have just been prescribed a GLP-1 drug for obesity or type 2 diabetes but have not yet started taking it - You have regular access to a smartphone and internet - You are willing to complete surveys and food records online **You may NOT be eligible if...** - You have already started taking your GLP-1 medication - You have medical concerns that make participation unsafe Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGGLP-1 Therapy

Exposure to GLP-1 Therapy for obesity or T2DM management.


Locations(2)

University South Carolina

Columbia, South Carolina, United States

Prisma Health Weight Management Institute

Greenville, South Carolina, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07313384


Related Trials